美国 · SEC FORM 4
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL · NYSE · CIK 0001100682 · Healthcare · Diagnostics & Research
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
89 同一窗口内观察到的 Form 4 交易行
19 sales · 69 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: EVP & Chief Financial Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-09-30 · Coleman Glenn.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,878,537
- 上期报告
- 2,230,517
- 日均成交量
- 1,071,070
- 回补天数
- 2.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Coleman Glenn | 买入 (P) | Common Stock | 10 | USD 297.43 | USD 2,974 | SEC 申报 ↗ |
| 2026-03-03 | LaPlume Joseph W | 买入 (P) | Common Stock | 25 | USD 174.54 | USD 4,364 | SEC 申报 ↗ |
| 2025-02-20 | Girshick Birgit | 买入 (P) | Common Stock | 1,514 | USD 164.63 | USD 249,250 | SEC 申报 ↗ |
| 2025-02-20 | FOSTER JAMES C | 买入 (P) | Common Stock | 6,075 | USD 165.01 | USD 1,002,436 | SEC 申报 ↗ |
| 2023-11-20 | Girshick Birgit | 买入 (P) | Common Stock | 1,322 | USD 187.82 | USD 248,298 | SEC 申报 ↗ |
| 2023-11-14 | FOSTER JAMES C | 买入 (P) | Common Stock | 5,620 | USD 178.05 | USD 1,000,641 | SEC 申报 ↗ |
| 2023-08-24 | WALLMAN RICHARD F | 买入 (P) | Common Stock | 1,000 | USD 198.79 | USD 198,790 | SEC 申报 ↗ |
| 2023-02-23 | WALLMAN RICHARD F | 买入 (P) | Common Stock | 1,750 | USD 220.73 | USD 386,278 | SEC 申报 ↗ |
| 2022-12-02 | WALLMAN RICHARD F | 买入 (P) | Common Stock | 1,500 | USD 218.90 | USD 328,350 | SEC 申报 ↗ |
| 2020-11-02 | WALLMAN RICHARD F | 买入 (P) | Common Stock | 7,200 | USD 233.20 | USD 1,679,006 | SEC 申报 ↗ |
Form 4 申报证据
107 transaction lines in the latest 365-day window; 994 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Parisotto Shannon M | 卖出 (S) | Common Stock | 981 | USD 308.44 | USD 302,580 | SEC 申报 ↗ |
| 2026-10-05 | Parisotto Shannon M | 期权行权／转换 (M) | Common Stock | 981 | USD 208.44 | USD 204,480 | SEC 申报 ↗ |
| 2026-09-30 | Coleman Glenn | 买入 (P) | Common Stock | 10 | USD 297.43 | USD 2,974 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Parisotto Shannon M | 卖出 (S) | Common Stock | 981 | USD 308.44 | USD 302,580 | SEC 申报 ↗ |
| 2026-10-05 | Parisotto Shannon M | 期权行权／转换 (M) | Common Stock | 981 | USD 208.44 | USD 204,480 | SEC 申报 ↗ |
| 2026-09-30 | Coleman Glenn | 买入 (P) | Common Stock | 10 | USD 297.43 | USD 2,974 | SEC 申报 ↗ |
| 2026-08-25 | FOSTER JAMES C | 卖出 (S) | Common Stock | 33,561 | USD 300.00 | USD 10,068,300 | SEC 申报 ↗ |
| 2026-08-25 | FOSTER JAMES C | 期权行权／转换 (M) | Common Stock | 33,561 | USD 199.42 | USD 6,692,845 | SEC 申报 ↗ |
| 2026-08-19 | Parisotto Shannon M | 卖出 (S) | Common Stock | 2,039 | USD 294.12 | USD 599,711 | SEC 申报 ↗ |
| 2026-08-19 | Parisotto Shannon M | 期权行权／转换 (M) | Common Stock | 2,039 | USD 194.12 | USD 395,811 | SEC 申报 ↗ |
| 2026-08-19 | Girshick Birgit | 赠与 (G) | Common Stock | 528 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-18 | Andrews Nancy C | 卖出 (S) | Common Stock | 573 | USD 285.24 | USD 163,443 | SEC 申报 ↗ |
| 2026-08-18 | Andrews Nancy C | 期权行权／转换 (M) | Common Stock | 573 | USD 164.30 | USD 94,144 | SEC 申报 ↗ |
| 2026-08-11 | Parisotto Shannon M | 卖出 (S) | Common Stock | 3,714 | USD 279.66 | USD 1,038,657 | SEC 申报 ↗ |
| 2026-08-11 | Parisotto Shannon M | 期权行权／转换 (M) | Common Stock | 3,714 | USD 179.66 | USD 667,257 | SEC 申报 ↗ |
| 2026-08-11 | Girshick Birgit | 卖出 (S) | Common Stock | 6,500 | USD 279.90 | USD 1,819,350 | SEC 申报 ↗ |
| 2026-08-11 | Girshick Birgit | 期权行权／转换 (M) | Common Stock | 6,500 | USD 179.66 | USD 1,167,790 | SEC 申报 ↗ |
| 2026-08-10 | LaPlume Joseph W | 赠与 (G) | Common Stock | 257 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-10 | FOSTER JAMES C | 卖出 (S) | Common Stock | 28,733 | USD 275.00 | USD 7,901,575 | SEC 申报 ↗ |
| 2026-08-10 | FOSTER JAMES C | 期权行权／转换 (M) | Common Stock | 28,733 | USD 179.66 | USD 5,162,171 | SEC 申报 ↗ |
| 2026-08-06 | Knell Michael Gunnar | 卖出 (S) | Common Stock | 6,645 | USD 260.38 | USD 1,730,250 | SEC 申报 ↗ |
| 2026-08-06 | Knell Michael Gunnar | 期权行权／转换 (M) | Common Stock | 2,345 | USD 196.12 | USD 459,909 | SEC 申报 ↗ |
| 2026-08-06 | Creamer Victoria L | 卖出 (S) | Common Stock | 4,179 | USD 259.16 | USD 1,083,030 | SEC 申报 ↗ |
| 2026-08-06 | Creamer Victoria L | 期权行权／转换 (M) | Common Stock | 4,179 | USD 179.66 | USD 750,799 | SEC 申报 ↗ |
| 2026-08-05 | Parisotto Shannon M | 卖出 (S) | Common Stock | 5,046 | USD 263.00 | USD 1,327,098 | SEC 申报 ↗ |
| 2026-06-29 | FOSTER JAMES C | 卖出 (S) | Common Stock | 75,000 | USD 225.00 | USD 16,875,000 | SEC 申报 ↗ |
| 2026-06-05 | Parisotto Shannon M | 赠与 (G) | Common Stock | 1,529 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Girshick Birgit | 赠与 (G) | Common Stock | 3,386 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | FOSTER JAMES C | 赠与 (G) | Common Stock | 183,361 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Barg Steven | 奖励／授予 (A) | Common Stock | 422 | USD 174.79 | USD 73,761 | SEC 申报 ↗ |
| 2026-05-31 | Parisotto Shannon M | 代扣税 (F) | Common Stock | 170 | USD 180.71 | USD 30,721 | SEC 申报 ↗ |
| 2026-05-31 | Mintz Mark | 代扣税 (F) | Common Stock | 64 | USD 180.71 | USD 11,565 | SEC 申报 ↗ |
| 2026-05-31 | LaPlume Joseph W | 代扣税 (F) | Common Stock | 235 | USD 180.71 | USD 42,467 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CRL |
| CIK | 0001100682 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8731 Services-Commercial Physical & Biological Research |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 994 transaction lines from 2020-01-06 to 2026-10-05 11 P purchase lines · 356 S sale lines · 627 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.